Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker Essential Pharma that will provide funds to expand its product portfolio and ...
Constructive regulation allows Essential to raise rates through surcharges or base rates to reduce regulatory lag and enhance cash flow available for the dividend and growth investments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results